Suche

Hexyon

filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid · J07CA09

Hexyon

Hexyon · 4.1 Therapeutic indications · 1

Hexyon · 4.3 Contraindications · 1

Hexyon · 4.3 · History of an anaphylactic reaction after a previous administration of Hexyon.

Hexyon · 4.3 · Hypersensitivity to the active substances, to any of the excipients listed in section 6.1, to trace residuals

Hexyon · 4.3 · Pertussis vaccine should not be administered to individuals with uncontrolled neurologic disorder or uncontrol